-
Researchers compare controlled release of bisphosphonates
11 Dec 2023 15:20 GMT
… release profiles of 15 bisphosphonate drugs along with kinetics … al, Structural Diversity in Antiosteolytic Bisphosphonates: Deciphering Structure–Activity Trends … :
Researchers compare controlled release of bisphosphonates (2023, December 11)
retrieved …
-
Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity
16 Nov 2023 22:47 GMT
… discuss the immunomodulatory properties of bisphosphonates, a class of drugs … osteoclast-mediated bone resorption, bisphosphonates can exert multifaceted immunomodulatory effects … study assessed whether prior bisphosphonate treatment impacted COVID-19 …
-
Bisphosphonate use before Primary THA May Elevate Risk of Periprosthetic Hip Fracture
20 Aug 2023 14:44 GMT
… (THA).
Researchers evaluated the bisphosphonate effect in treating osteoporotic patients … #47; medications for osteoporosis.
Bisphosphonate users and those who were … between bisphosphonate users and bisphosphonate naïve patients.
They said bisphosphonate use …
-
Bone anabolic treatments better than bisphosphonates for fracture prevention among postmenopausal women.
08 May 2023 22:06 GMT
… cardiovascular adverse events.
Key findings:
Bisphosphonates, parathyroid hormone receptor agonists, … were more effective than oral bisphosphonates in preventing vertebral fractures.
… bone anabolic therapy over bisphosphonates in preventing clinical and …
-
Bisphosphonate use prior to THA may be risk factor for periprosthetic fracture
10 Mar 2023 09:06 GMT
… Serino said. “Bisphosphonate naïve patients had no bisphosphonate exposure during the … of periprosthetic fractures compared to bisphosphonate naïve patients,” Serino said. … not reach statistical significance.
“Bisphosphonate users undergoing cemented total …
-
Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
31 Jan 2023 10:44 GMT
… this study found that bisphosphonates, denosumab, abaloparatide, teriparatide … . Included interventions were bisphosphonates (alendronate, ibandronate, risedronate … that several medications, including bisphosphonates, denosumab, abaloparatide, teriparatide …
-
New Osteoporosis Guideline Says Start With a Bisphosphonate
03 Jan 2023 21:09 GMT
… pharmacologic interventions:
Antiresorptive drugs: four bisphosphonates (alendronate, ibandronate, risedronate, zoledronate) and … experience adverse effects with bisphosphonates.
The choice among bisphosphonates (alendronate, risedronate, zoledronic …
-
Bisphosphonates initial treatment for primary osteoporosis for fracture prevention recommends ACP guideline
04 Jan 2023 00:19 GMT
… Physicians (ACP) has recommended bisphosphonates as initial pharmacologic treatment to … males with primary osteoporosis, bisphosphonates had the most favorable balance … , clinicians should consider stopping bisphosphonates after five years of treatment …
-
American College of Physicians recommends bisphosphonates for initial treatment for osteoporosis in males and postmenopausal females diagnosed with primary osteoporosis
03 Jan 2023 06:57 GMT
… College of Physicians recommends bisphosphonates for initial treatment for osteoporosis … new guideline, ACP recommends bisphosphonates as initial pharmacologic treatment to … , clinicians should consider stopping bisphosphonates after five years of treatment …
-
Bisphosphonate use does not raise mortality risk with atypical femur fractures
28 Jul 2022 14:51 GMT
… clinical characteristics of bisphosphonate- and non-bisphosphonate-related atypical … assessing differences in bisphosphonate- and non-bisphosphonate-related atypical femur … major differences between bisphosphonate- and non-bisphosphonate-exposed atypical …